Aktienanalyse zu BIO-Key International Inc (BKYI)BKYIBIO-Key International Inc

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

BIO-Key International Inc is a good buy right now due to its recent 57.49% price increase over the last 5 days and a gross margin of 87.19% in Q2 2026, indicating strong profitability potential. The current price of $2.63 is well below its Fibonacci resistance levels, suggesting room for growth. However, the main risk is the negative earnings per share of -0.56 reported in Q2 2026, which reflects ongoing financial challenges.

1 analysts cover BKYI: 1 rate it Buy, 0 Hold and 0 Sell.